Mersana Therapeutics
MRSN
MRSN
152 hedge funds and large institutions have $590M invested in Mersana Therapeutics in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 68 increasing their positions, 37 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 152 → 152 (0)
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
152
Holding in Top 10
3
Calls
$512K
Puts
$469K
Top Buyers
| 1 | +$11.7M | |
| 2 | +$10.5M | |
| 3 | +$5.57M | |
| 4 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
+$3.32M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$3.07M |
Top Sellers
| 1 | -$3.09M | |
| 2 | -$2.58M | |
| 3 | -$2.54M | |
| 4 |
Goldman Sachs
New York
|
-$2.28M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.69M |